Patient
SITE005-0212
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE005 (FRA) (Dr. Muller)
consented 2026-05-04
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
moderate
assessed
2026-08-17
Grade 2 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2023-02-10 (study day 91); relationship: not assessed
mild
assessed
2026-07-11
Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2023-01-04 (study day 54); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.